News

Vergent Biosciences raises $21.5M | Health IT

By October 4, 2022No Comments

Vergent Biosciences, a biotech company specializing in imaging agents, has raised $21.5 million in series B financing.Health IT

Leave a Reply Cancel Reply

The Washington Metropolitan Area Chapter(WMAC) of the National Association of Health Services Executives (NAHSE) was chartered in 1978 to educate and develop minority healthcare leaders while, in conjunction with the American College of Healthcare Executives (ACHE), promoting C-Suite diversity for Healthcare Organizations throughout Northern Virginia, Southern Maryland, and the District of Columbia. The Washington Metropolitan Area Chapter (WMAC) was one of the first two chapters founded by the Association, since its inception.

Vergent Biosciences raises $21.5M | Health IT

Tags:

Previous PostKatalyst raises $26M | Health IT

Next PostParticle Health launches EHR data sharing tool | Health IT

Leave a Reply Cancel Reply

Join the NAHSE-WMAC Mailing List

Contact Us